SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-029442
Filing Date
2023-08-18
Accepted
2023-08-18 16:15:29
Documents
13
Period of Report
2023-08-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42109
2 ex16-1.htm EX-16.1 3930
  Complete submission text file 0001493152-23-029442.txt   218034

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xtnt-20230815.xsd EX-101.SCH 3027
4 XBRL LABEL FILE xtnt-20230815_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE xtnt-20230815_pre.xml EX-101.PRE 22797
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3120
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 231186030
SIC: 2836 Biological Products, (No Diagnostic Substances)